PUTRAJAYA: Malaysia has approved the conditional registration of the CoronaVac Suspension for Injection Covid-19 vaccine (Vero Cell), says the Health Ministry.
Health director-general Tan Sri Dr Noor Hisham Abdullah (pic) said in a statement the decision was made during the 356th Drug Control Authority meeting on Friday (April 23).
The product is developed by Sinovac Life Sciences Co Ltd, China.
Pharmaniaga LifeScience Sdn Bhd (PLS) is carrying out the fill-and-finish process of the vaccine.
Before this, Malaysia has also given conditional approval to the finished doses of the CoronaVac vaccine which is produced by Sinovac in China.
Dr Noor Hisham said the deal for PLS to carry out the fill-and-finish process of the CoronaVac vaccine is an achievement for Malaysia, which has been relying on imported vaccine and plasma products.
“Hopefully, this development can spur the growth of the local pharmaceutical industry," he said.
In January, PLS signed an agreement with Sinovac to import 14 million doses Covid-19 vaccines, which will then be “filled-and-finished” at its facilities in Puchong, Selangor.
Fill-and-finish is the process of filling vials with vaccines and finishing the process of packaging the medicine for distribution.